th those are objectives my um The Wall Street Journal may be worried about shareholder value for pharmaceutical companies and I think you know I talk specifically to president Trump about that issue and he said that he wanted to leave as his legacy healthy children and that you know that he he that he was unconcerned about the other implications all right